Cost-Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry

Thijssen, J.; Marle, M.E.V. van; Borleffs, C.J.W.; Rees, J.B. van; Bie, M.K. de; Velde, E.T. van der; ... ; Schalij, M.J. (2014)

Article / Letter to editor

• cost-benefit analysis
• implantable cardioverter defibrillator
• left ventricular ejection fraction
• primary prevention

• All authors: Thijssen, J.; Marle, M.E.V. van; Borleffs, C.J.W.; Rees, J.B. van; Bie, M.K. de; Velde, E.T. van der; Erven, L. van; Schalij, M.J.
• Date: 2014-01-31
• Journal: Pacing and Clinical Electrophysiology
• Volume: 37
• Issue: 1
• Pages: 25 - 34
• DOI: doi:10.1111/pace.12238